TY  - BOOK
AU  - Finegold,David
TI  - Bioindustry ethics
SN  - 9780123693709
AV  - HD9999.B442 B542 2005eb
U1  - 174/.96606 22
CY  - Amsterdam, Boston
PB  - Elsevier Academic Press.
KW  - Biotechnology industries
KW  - Moral and ethical aspects
KW  - Case studies
KW  - Pharmaceutical industry
KW  - Business ethics
KW  - Bioethics
KW  - Biotechnology
KW  - ethics
KW  - Drug Industry
KW  - Ethics, Business
KW  - Bio-industries
KW  - Aspect moral
KW  - Cas, Études de
KW  - Industrie pharmaceutique
KW  - Morale des affaires
KW  - BUSINESS & ECONOMICS
KW  - Business Ethics
KW  - bisacsh
KW  - Electronic books
N1  - Includes index; Includes bibliographical references and index; Preface -- Introduction -- Leadership -- Starting Right -- Ethics in an Emerging Field -- Getting Advice -- Self-Assessment -- Endnotes
N2  - This book is the first systematic, detailed treatment of the approaches to ethical issues taken by biotech and pharmaceutical companies. The application of genetic/genomic technologies raises a whole spectrum of ethical questions affecting global health that must be addressed. Topics covered in this comprehensive survey include considerations for bioprospecting in transgenics, genomics, drug discovery, and nutrigenomics, as well as how to improve stakeholder relations, design ethical clinical trials, avoid conflicts of interest, and establish ethics advisory boards. The expert authors represent multiple disciplines including law, medicine, bioinformatics, pharmaceutics, business, and ethics
UR  - http://www.sciencedirect.com/science/book/9780123693709
ER  -